| Literature DB >> 34449559 |
Jaideep Mahendra1, Little Mahendra2, Maryam H Mugri3, Mohammed E Sayed4, Shilpa Bhandi5, Rahaf Turki Alshahrani6, Thodur Madapusi Balaji7, Saranya Varadarajan8, Swetha Tanneeru9, Abirami Nayaki Rao P1, Sruthi Srinivasan1, Rodolfo Reda10, Luca Testarelli10, Shankargouda Patil11.
Abstract
Previous studies assessed the involvement and impact of periodontal bacteria in preeclamptic women with chronic periodontitis. To explore further, the current study aimed to associate periodontal viruses and bacteria with mir155 levels in placental tissues of preeclamptic women with generalized chronic periodontitis. Four-hundred 45 pregnant women, 18-35 years of age, were selected and divided into four groups (controls, A, B, and C) where the Controls included 145 systemically and periodontally healthy pregnant women Group A-100 systemically healthy pregnant women with chronic periodontitis, Group B- 100 preeclamptic women with chronic periodontitis, Group C- 100 preeclamptic women without chronic periodontitis. Age, BMI, SES, and periodontal parameters such as PI, BOP, PPD, and CAL were noted. Periodontal pathogens such as Tf, Td, Pg, Pi, Fn, HSV, EBV, and HCMV were tested in subgingival plaque, placental tissues, and mir155. We observed that PI, BOP, PPD, CAL, Tf, and EBV were highly significant in Group B. We found a higher number of periodontal bacteria, viruses, and mir 155 in Group B showing a higher risk of preeclampsia. More genetic studies in this field are advised to ascertain the role of periodontopathogens and mir 155 in preeclampsia and periodontal inflammation. What is already known on this subject? Periodontal diseases pose an increased risk of developing preeclampsia and delivering preterm and/or low-birth-weight babies. What do the results of this study add? Periodontal variables such as PI, pocket depth, BOP, and clinical attachment levels, were found to be increased in the preeclamptic women with chronic periodontitis. The significant difference was seen in the relative fold expression of mir155 with higher gene expression of mir155 in groups B and A as compared to group C and controls. What are the implications of these findings for clinical practice and/or further research? In our study, mir155 correlation with the periodontal parameters and periodontal pathogens further strengthen the evidence of periodontal inflammation as a risk of preeclampsia in pregnant women especially when associated with chronic periodontitis. mir155 can be considered to be one of the genetic biomarkers and can be used as a diagnostic tool for the early detection of PE.Entities:
Keywords: chronic periodontitis; mir 155; periodontal microflora; preeclampsia; pregnancy
Mesh:
Substances:
Year: 2021 PMID: 34449559 PMCID: PMC8929077 DOI: 10.3390/cimb43020060
Source DB: PubMed Journal: Curr Issues Mol Biol ISSN: 1467-3037 Impact factor: 2.976
Figure 1Study flow chart.
Primer sequences of Putative Periodontopathic microorganisms bacteria (Pg, Tf, Td, Pi, and Fn), viruses (HSV, EBV, and HCMV), and MIR155.
| Periodontapothic | Primer Sequence (5′–3′) | Primer Length | Amplified | |
|---|---|---|---|---|
|
| ATTGTGGCTAAAAATTATAGTT | (FP) | 22 | 817 |
|
| AGGCAGCTTGCCATACTGCG | (FP) | 20 | 404 |
|
| CGTGGACCAAAGATTCATCGGTGGA | (FP) | 26 | 259 |
|
| GCGTATGTAACCTGCCCGCA | (FP) | 21 | 641 |
|
| TAATACCGAATGTGCTCATTTACAT | (FP) | 26 | 316 |
| Epstein-Barr virus inner | AGGCTGCCCACCCTGAGGAT | (FP) | 21 | 168 |
| Herpes simplex virus inner | CAGTTCGGCGGTGCGGACAAA | (FP) | 22 | 222 |
| Human cytomegalovirus inner primer | AGTGTGGATGACCTACGGGCCATCG | (FP) | 25 | 110 |
|
| 5‘-CTAGCCTGCAGGTATTCAAATATTTCCACAGA-3′ | (FP) | ||
|
| 5′-AAAATATGGAACGCTTCACGAATT-3′, | |||
|
| 5′- CTCGCTTCGGCAGCACATATACT-3′ | (FP) | ||
PCR conditions and reaction set up for Bacteria and Viruses.
| Periodontapothic | Initial | De | Annealing | Extension | Cycles | Final |
|---|---|---|---|---|---|---|
| Fusobacterium nucleatum | 94 °C FOR 5 min | 94 °C FOR 30 s | 55 °C FOR 30 s | 72 °C FOR 30 s | 30 | 72 °C FOR 3 min |
| Porphyromonas gingivalis | 94 °C FOR 5 min | 94 °C FOR 30 s | 55 °C FOR 30 s | 72 °C FOR 30 s | 30 | 72 °C FOR 3 min |
| Prevotella intermedia | 94 °C FOR 3 min | 94 °C FOR 30 s | 55 °C FOR 30 s | 72 °C FOR 20 s | 30 | 72 °C FOR 3 min |
| Tannerella forsythia | 94 °C FOR 3 min | 94 °C FOR 30 s | 55 °C FOR 30 s | 72 °C FOR 30 s | 30 | 72 °C FOR 3 min |
| Treponema denticola | 94 °C FOR 5 min | 94 °C FOR 30 s | 55 °C FOR 30 s | 72 °C FOR 20 s | 30 | 72 °C FOR 3 min |
| EBV INNER | 94 °C FOR 3 min | 94 °C FOR 30 s | 63 °C FOR 15 s | 72 °C FOR 30 s | 30 | 72 °C FOR 3 min |
| Hsv INNER | 94 °C FOR 1 min | 94°C FOR 1 min | 55 °C FOR 1 min | 72 °C FOR 30 s | 35 | 72 °C FOR 30 s |
| HCMV | 94 °C FOR 5 min | 94 °C FOR 30 s | 59 °C FOR 30 s | 72 °C FOR 30 s | 25 | 72 °C FOR 3 min |
| MIR155 | 94 °C FOR 2 min | 94 °C FOR 30 s | 59 °C FOR 30 s | 72 °C FOR 30 s | 35 | 72 °C FOR 30 s |
Reaction setup for bacteria and viruses with final concentration.
| Component | 25 µL Reaction | Final Concentration |
|---|---|---|
| Luna Universal qPCR Master Mix | 10 µL | 1 X |
| Forward primer (10 µM) | 1 µL | 0.4 µM |
| Reverse primer (10 µM) | 1 µL | 0.4 µM |
| Template DNA | Variable | <100 ng |
| Nuclease-free Water | to 25 µL |
Intergroup Comparison of demographic and periodontal variables in between the groups.
| Variables | Controls | Group A | Group B | Group C | |
|---|---|---|---|---|---|
| Age | 21.71 ± 1.92 | 22.14 ± 2.27 | 21.72 ± 1.95 | 22.21 ± 2.22 | 0.147 † |
| Weight | 57.01 ± 4.74 | 56.89 ± 4.52 | 56.83 ± 4.87 | 57.11 ± 4.85 | 0.975 † |
| BMI | 23.11 ± 2.89 | 24.99 ± 17.99 | 23.04 ± 2.51 | 24.46 ± 17.92 | 0.556 † |
| SES | 18.64 ± 5.21 | 19.39 ± 4.35 | 19.46 ± 4.27 | 19.69 ± 4.34 | 0.296 † |
| DBP | 78.61 ± 3.59 | 78.63 ± 3.69 | 93.00 ± 7.32 | 92.90 ± 7.15 | <0.0001 * |
| SBP | 118.15 ± 7.04 | 118.35 ± 6.97 | 144.78 ± 5.53 | 144.49 ± 5.70 | <0.0001 * |
| Urine protein | 16.87 ± 3.94 | 17.31 ± 3.85 | 35.11 ± 2.96 | 34.75 ± 320 | <0.0001 * |
| PI | 0.77 ± 0.22 | 1.62 ± 0.67 | 1.59 ± 0.67 | 1.86 ± 1.08 | <0.0001 * |
| BOP | 1.36 ± 0.59 | 4.07 ± 3.24 | 4.68 ± 5.49 | 1.00 ± 0.44 | <0.0001 * |
| CAL | 0.87 ± 0.23 | 8.25 ± 1.02 | 3.53 ± 1.05 | 0.87 ± 0.23 | <0.0001 * |
| PPD | 2.76 ± 0.63 | 5.21 ± 0.99 | 5.20 ± 0.98 | 2.79 ± 0.62 | <0.0001 * |
* —Significant, † —No Significant, p-value ≤ 0.05 considered statistically significant. Age, BMI expressed as Mean ± SD. BMI—Body mass index, socioeconomic status (SES), Diastolic blood pressure (DBP), Systolic blood pressure (SBP). Controls–systemically and periodontally healthy pregnant women. Group A–systemically healthy pregnant women with chronic periodontitis Group B–preeclamptic pregnant women with chronic periodontitis. Group C–preeclamptic pregnant women without chronic periodontitis.
Comparison of the presence of bacteria and viruses in subgingival plaque and placental tissue samples in between the groups.
| Periodontal Microorganisms | Controls | Group A | Group B | Group C | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Range | Mean ± SD | Range | Mean ± SD | Range | Mean ± SD | Range | |||
|
| Sub gingival Plaque | 2.4 × 105 | (5.8 × 102–4.24 × 106) | 4.26 × 106 | (2.4 × 103–1.85 × 107) | 5.42 × 107 | (2.44 × 103–6.41 × 108) | 5.25 × 106 | (2.2 × 102–9.5 × 106) | 0.07 † |
| Placental tissue | 2.6 × 105 | (5.4 × 102–4.21 × 106) | 2.81 × 106 | (2.2 × 103–1.5 × 107) | 4.25 × 107 | (2.44 × 103–5.2 × 108) | 4.2 × 106 | (2.7 × 102–5.2 × 106) | 0.07 † | |
|
| Sub gingival Plaque | 2.4 × 105 | (1.6 × 102–5.2 × 106) | 4.2 × 106 | (2.8 × 102–9.2 × 107) | 4.25 × 108 | (5.6 × 103–8.62 × 1× 109) | 3.2 × 104 | (5.6 × 102–4.25 × 106) | 0.062 † |
| Placental tissue | 2.2 × 105 | (2.2 × 102–5.5 × 106) | 4.6 × 106 | 3.5 × 102–7.8 × 107) | 5.25 × 108 | (7.9 × 103–8.58 × 109) | 3.5 × 104 | (4.2 × 102–8.8 × 106) | 0.045 * | |
|
| Sub gingival Plaque | 4.25 × 106 | (3.12 × 102–6.52 × 107) | 5.92 × 106 | (1.59 × 102–7.8 × 107) | 8.48 × 106 | (2.56 × 103–5.8 × 109) | 4.22 × 105 | (5.8 × 102–2.6 × 107) | 0.042 * |
| Placental tissue | 3.9 × 106 | (2.12 × 102 –5.55 × 1× 107) | 5.54 × 106 | (2.45 × 102–2.8 × 107) | 8.2 × 108 | (1.56 × 103–4.1 × 109) | 5.15 × 105 | (4.2 × 102–4.6 × 106) | 0.04 * | |
|
| Sub gingival plaque | 1.72 × 107 | (9.28 × 102–3.23 × 108) | 7.24 × 107 | (1.82 × 104–7.97 × 107 | 7.52 × 108 | (1.86 × 105–8.11 × 108) | 1.24 × 106 | (2.86 × 105–4.2 × 106) | 0.005 * |
| Placental tissue | 1.6 × 105 | (2.6 × 102–5.4 × 106) | 3.9 × 106 | (2.9 × 102–2.4 × 107) | 5.58 × 106 | (54.5 × 103–7.5 × 109) | 2.9 × 104 | (3.5 × 102–4.25 × 106) | 0.05 * | |
|
| Sub gingival plaque | 1.29 × 104 | (4.52 × 102–8.62 × 105) | 2.2 × 106 | (2.32 × 103–4.22 × 107) | 7.22 × 108 | (2.44 × 103–5.82 × 109) | 1.55 × 106 | (4.2 × 102–8.48 × 106) | 0.045 * |
| Placental tissue | 2.22 × 104 | (3.45 × 102–6.5 × 105) | 4.2 × 106 | (3.32 × 103–2.27 × 107) | 6.52 × 108 | (2.54 × 103–5.44 × 109) | 1.27 × 106 | (4.5 × 102–8.6 × 106) | 0.065 † | |
| HSV | Sub gingival Plaque | 4.8 × 106 | (5.5 × 104–9.24 × 106) | 4.55 × 107 | (2.6 × 103–4.8 × 108) | 4.9 × 107 | (4.4 × 103–5.4 × 108) | 2.5 × 106 | (4.2 × 104–9.5 × 107) | 0.072 † |
| Placental tissue | 3.2 × 106 | (2.9 × 103–5.5 × 107) | 7.6 × 108 | 4.5 × 103–4.8 × 109) | 8.2 × 109 | (8.7 × 104–8.6 x1010) | 2.5 × 106 | (2.2 × 102–9.8 × 106) | 0.02 * | |
| EBV | Sub gingival plaque | 2.4 × 108 | (3.12 × 102–6.52 × 107) | 5.22 × 107 | (2.87 × 103–7.8 × 108 | 8.7 × 107 | (2.42 × 104–4.8 × 109) | 6.85 × 106 | (4.4 × 103–5.2 × 107) | 0.004 * |
| Placental tissue | 4.2 × 106 | (5.6 × 103–4.9 × 108) | 8.6 × 108 | (2.5 × 102–7.2 × 109) | 7.4 × 1× 108 | (2.6 × 104–5.5 × 109) | 2.6 × 106 | (4.5 × 104–7.2 × 107) | 0.005 * | |
| HCMV | Sub gingival plaque | 4.25 × 108 | (6.22 × 103–8.62 × 108) | 4.8 × 108 | (4.15 × 103–4.11 × 109) | 6.85 × 106 | (4.58 × 104–7.85 × 109) | 8.9 × 107 | (2.5 × 103–4.48 × 107) | 0.042 * |
| Placental tissue | 3.25 × 106 | (4.2 × 102–5.9 × 107) | 4.6 × 107 | (2.7 × 103–1.5 × 108) | 7.8 × 108 | (2.6 × 103–5.6 × 109) | 4.9 × 106 | (1.7 × 103–5.5 × 107) | 0.03 * | |
* —Significant, † —No Significant. p-value ≤ 0.05 considered statistically significant. Tannerella forsythia (Tf), Treponema denticola (Td), Porphyromonas gingivalis (Pg), Prevotella intermedia (Pi), Fusobacterium nucleatum (Fn). Herpes Simplex Virus (HSV), Ebstein Barr Virus (EBV), and Human Cytomegalovirus (HCMV). Controls–systemically and periodontally healthy pregnant women. Group A–systemically healthy pregnant women with chronic periodontitis. Group B–preeclamptic pregnant women with chronic periodontitis. Group C–preeclamptic pregnant women without chronic periodontitis.
Correlation of mir155 with Periodontal Microorganisms among Groups.
| Microorganisms | Group 1 | Group 2 | Group 3 | Group 4 | |
|---|---|---|---|---|---|
|
|
|
|
| ||
| BOP | Corelation | 0.013 | –0.123 | –0.079 | –0.019 |
| 0.004 * | 0.255 | 0.626 | 0.821 | ||
| PI | Corelation | –0.010 | –0.199 | –0.019 | 0.048 |
| 0.513 | 0.160 | 0.313 | 0.030 * | ||
| PPD | Corelation | 0.042 | –0.042 | 0.066 | –0.016 |
| 0.037 * | 0.510 | 0.033 * | 0.638 | ||
| CAL | Corelation | 0.029 | –0.014 | 0.008 | –0.005 |
| 0.410 | 0.489 | 0.045 * | 0.950 | ||
|
| Corelation | –0.062 | –0.054 | –0.082 | –0.054 |
| 0.463 | 0.524 | 0.332 | 0.524 | ||
|
| Corelation | –0.008 | –0.054 | 0.068 | –0.080 |
| 0.920 | 0.524 | 0.425 | 0.341 | ||
|
| Corelation | –0.052 | –0.043 | –0.043 | –0.065 |
| 0.538 | 0.613 | 0.613 | 0.440 | ||
|
| Corelation | –0.082 | –0.042 | 0.051 | –0.166 |
| 0.332 | 0.619 | 0.045 * | 0.047 * | ||
|
| Corelation | –0.025 | –0.082 | –0.121 | –0.082 |
| 0.767 | 0.330 | 0.152 | 0.330 | ||
| HSV | Corelation | 0.072 | 0.073 | 0.076 | 0.071 |
| 0.039 * | 0.039 * | 0.041 * | 0.039 * | ||
| EBV | Corelation | 0.052 | 0.133 | 0.054 | –0.090 |
| 0.536 | 0.112 | 0.322 | 0.285 | ||
| HCMV | Corelation | 0.027 | 0.027 | 0.027 | 0.072 |
| 0.752 | 0.752 | 0.752 | 0.394 | ||
* —Significant. p-value ≤ 0.05 considered statistically significant. Tannerella forsythia (Tf), Treponema denticola (Td), Porphyromonas gingivalis (Pg), Prevotella intermedia (Pi), Fusobacterium nucleatum (Fn). Herpes Simplex Virus (HSV), Ebstein Barr Virus (EBV), and Human Cytomegalovirus (HCMV). Controls–systemically and periodontally healthy pregnant women. Group A–systemically healthy pregnant women with chronic periodontitis. Group B–preeclamptic pregnant women with chronic periodontitis. Group C–preeclamptic pregnant women without chronic periodontitis.
Figure 2Relative fold expression of MIR155 among groups. Controls: 145 Systematically and periodontally healthy pregnant women. Group A: 100 Systematically healthy pregnant women with chronic periodontitis. Group B: 100 Preeclamptic pregnant woman with chronic periodontitis. Group C: 100 Preeclamptic pregnant woman without chronic periodontitis. * statistically significant, *** highly statistically significant. ‖‖ Version V, SanDiego, CA, USA.